Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
HER2CLIMB-05 trial evaluated Tukysa in combination with Herceptin and Perjeta for HER2-positive metastatic breast cancer, ...
Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.
Zanidatamab plus chemotherapy delays progression or death in patients with untreated locally advanced or metastatic gastroesophageal adenocarcinoma.
News-Medical.Net on MSN
Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback